Browse Tag

cancer

Breast Cancer Diagnosis in the ‘Between’ Year: Body Mass Index Matter

3 mins read

The FINANCIAL — While mammograms reduce breast cancer mortality by 15-20%, the diagnosis in many cases—approximately 15% of all breast cancers—occurs after a patient has a negative mammogram and before her next recommended screening. These are “interval cancers,” and they carry big implications. Patients who receive a cancer diagnosis during the interim see poorer outcomes than those whose cancers show up in screening. Yet some practical gaps in the research have persisted, says Anne Marie McCarthy, assistant professor of epidemiology, according to University of Pennsylvania.…

Read More »

Breast Cancer Diagnosis in the ‘Between’ Year: Body Mass Index Matter

3 mins read

The FINANCIAL — While mammograms reduce breast cancer mortality by 15-20%, the diagnosis in many cases—approximately 15% of all breast cancers—occurs after a patient has a negative mammogram and before her next recommended screening. These are “interval cancers,” and they carry big implications. Patients who receive a cancer diagnosis during the interim see poorer outcomes…

Vaccine for treating cancer made possible using Oxford COVID vaccine technology

6 mins read

The FINANCIAL — Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer. Researchers have designed a two-dose therapeutic cancer vaccine using Oxford’s viral vector vaccine technology.…

International study of rare childhood cancer finds genetic clues, potential for tailored therapy

6 mins read

The FINANCIAL -- In children with rhabdomyosarcoma, or RMS, a rare cancer that affects the muscles and other soft tissues, the presence of mutations in several genes, including TP53, MYOD1, and CDKN2A, appears to be associated with a more aggressive form of the disease and a poorer chance of survival. This finding is from the largest-ever…

Researchers aim to develop tiny robotic sensors to detect bowel cancers

9 mins read

The FINANCIAL --  Researchers aim to develop tiny robotic sensors to detect bowel cancers, the second most common cause of cancer death in the UK. Armed with cutting edge terahertz imaging, the sensors could be used in colonoscopies or even to detect skin tumours, allowing for diagnosis in situ without having to wait for biopsy results…

Some postmenopausal women with common breast cancer may forgo chemotherapy

7 mins read

The FINANCIAL -- Postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low, do not benefit from chemotherapy when it is added to hormone therapy, according to initial results from a clinical trial…

Should people still get screened for cancer during this pandemic?

41 mins read

The FINANCIAL -- The global pandemic of the coronavirus disease, called COVID-19, continues to have a serious impact on many people, including cancer patients, their families, and caregivers. State and local authorities, as well as health officials, continue to adjust their recommendations as the number of COVID-19 cases changes in different parts of…

Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer

5 mins read

The FINANCIAL — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the China National Medical Products Administration (NMPA) has approved XTANDI® (enzalutamide soft capsules) for the treatment of adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) with high risk of metastasis. This is the second approved indication in China for enzalutamide, which is…

EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer

4 mins read

The FINANCIAL — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy. “Tecentriq in combination with Avastin is the first treatment to be…

Roche’s Tecentriq in combination with Avastin approved in China for people with liver cancer

6 mins read

The FINANCIAL — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the China National Medical Products Administration (NMPA) has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy. “Today’s approval of Tecentriq in combination with Avastin for unresectable hepatocellular carcinoma…

Eddie Van Halen Lost His battle With Throat Cancer

11 mins read

Eddie Van Halen, the virtuoso guitarist whose innovative and blistering solos helped propel the band named after him into one of rock’s biggest acts in the 1980s, has died of cancer. He was 65.…

ME? Cancer! Now What?

2 mins read

You’ve just left the doctor’s office and you’ve heard the dreaded diagnosis, “You have cancer.” Once you receive that diagnosis, then what?…

Cancer-detection company GRAIL files to go public

6 mins read

The FINANCIAL — GRAIL, a healthcare company yesterday, on September 9 announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) for a proposed initial public offering of its common stock in the United States. The number of shares to be offered and the price range for the…

Is 5G dangerous for health?

5 mins read

The FINANCIAL — Parts of the community are concerned about the safety of 5G network. Could it pose health risks? The International Commission on Non‐Ionizing Radiation Protection (ICNIRP) has released new guidelines for the protection of humans exposed to radiofrequency electromagnetic fields. In 2019 the Portland, Oregon, city council passed a resolution asking the Federal…

1 in 4 deaths in EU caused by cancer

2 mins read

Almost 1.2 million persons died from cancer in the European Union in 2016. Cancer was responsible for over one quarter (26%) of all deaths recorded in the EU.…

U.S.: 220 Cancer Patient Campaigns Raised $1.4 Million

3 mins read

"Crowdfunding" campaigns for the homeopathic treatment of cancer are overwhelmingly an American phenomenon and can be highly successful in terms of dollars raised, despite no evidence of efficacy, indicates a new study published January 1 in the Lancet Oncology, published by Medscape.com …